Gilead Sciences (GILD) Times Interest Earned (2009 - 2026)
Gilead Sciences (GILD) posted Times Interest Earned of $10.78 for Q1 2026, up 38.49% quarter-over-quarter from $7.78 in Q4 2025, and up 25.23% year-on-year from $8.6 in Q1 2025.
Gilead Sciences (GILD) Times Interest Earned (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Times Interest Earned for 18 consecutive years, with $10.78 the latest figure, recorded in Q1 2026.
- Times Interest Earned for Q1 2026 came in at $10.78, up 25.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.32 (up 23.52% YoY), and the FY2025 annual result was $9.79, up 475.33% from the prior year.
- Times Interest Earned was $10.78 for Q1 2026 at Gilead Sciences, up from $7.78 in the prior quarter.
- Over five years, Times Interest Earned peaked at $13.0 in Q3 2025 and troughed at -$17.02 in Q1 2024.
- Average Times Interest Earned over 5 years is $7.15, with a median of $8.6 recorded in 2025.
- Year-over-year, Times Interest Earned jumped 795.59% in 2023 and plunged 329.54% in 2024.
- Over 5 years, Times Interest Earned stood at $10.03 in 2022, then slumped by 36.23% to $6.4 in 2023, then jumped by 53.94% to $9.85 in 2024, then decreased by 20.99% to $7.78 in 2025, then surged by 38.49% to $10.78 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $10.78 in Q1 2026, $7.78 in Q4 2025, and $13.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.78 |
| Dec 31, 2025 | 7.78 |
| Sep 30, 2025 | 13.00 |
| Jun 30, 2025 | 9.74 |
| Mar 31, 2025 | 8.60 |
| Dec 31, 2024 | 9.85 |
| Sep 30, 2024 | 3.73 |
| Jun 30, 2024 | 11.16 |
| Mar 31, 2024 | -17.02 |
| Dec 31, 2023 | 6.40 |
| Sep 30, 2023 | 11.31 |
| Jun 30, 2023 | 7.24 |
| Mar 31, 2023 | 7.41 |
| Dec 31, 2022 | 10.03 |
| Sep 30, 2022 | 12.39 |
| Jun 30, 2022 | 8.38 |
| Mar 31, 2022 | 0.83 |
| Dec 31, 2021 | 3.95 |
| Sep 30, 2021 | 15.37 |
| Jun 30, 2021 | 8.77 |